| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A critical evaluation of the EFS endpoint in AML: Does induction treatment failure timing have a profound impact on study design and results?
|
Sidi, Yulia
|
|
|
138 |
C |
p.
|
artikel
|
| 2 |
Adipose tissue indices predict prognosis in hodgkin lymphoma
|
Özbalcı, Demircan
|
|
|
138 |
C |
p.
|
artikel
|
| 3 |
Bortezomib modulated the autophagy-lysosomal pathway in a TFEB-dependent manner in multiple myeloma
|
Zhang, Rongjuan
|
|
|
138 |
C |
p.
|
artikel
|
| 4 |
Clinical features and management of germline CEBPA-mutated carriers
|
Pan, Lili
|
|
|
138 |
C |
p.
|
artikel
|
| 5 |
Clinical outcomes of patients with acute myeloid leukemia and cardiovascular disease
|
Sanchez-Petitto, Gabriela
|
|
|
138 |
C |
p.
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
138 |
C |
p.
|
artikel
|
| 7 |
KRAS mutations, autoimmunity and female sex in chronic myelomonocytic leukemia
|
Osman, Afaf E.G.
|
|
|
138 |
C |
p.
|
artikel
|
| 8 |
Phytostilbenes in lymphoma: Focuses on the mechanistic and clinical prospects of resveratrol, pterostilbene, piceatannol, and pinosylvin
|
Goleij, Pouya
|
|
|
138 |
C |
p.
|
artikel
|
| 9 |
Proteomic analysis of adult T-cell leukemia/lymphoma: A biomarker identification strategy based on preparation and in-solution digestion methods of total proteins
|
Sudo, Haruka
|
|
|
138 |
C |
p.
|
artikel
|
Tijdschrift beschrijving